The JID Connector offers online-only articles of direct clinical relevance for the dermatology and skin biology communities.


This Month's Highlights

Maho-Vaillant et al. demonstrate that long-lasting efficacy of rituximab treatment in pemphigus patients results from long-lasting depletion of desmoglein-specific B cells in combination with altered maturation and class-switching of these cells. These changes likely stem from diminished desmoglein-specific T follicular helper cells, which are associated with the anti-desmoglein 3 response in patients with pemphigus. To learn more about the techniques used in this paper, visit this Research Techniques Made Simple article.
Rahim et al. describe regulation of keratinocyte differentiation by AMD1, a regulator of polyamine levels that are altered in skin disorders and skin cancer. AMD1 protein, which is upregulated during keratinocyte differentiation, alters putrescine and spermine ratios, leading to transcription factor and signaling protein expression changes to drive cellular changes. These findings suggest that modulation of polyamines may be useful in the treatment of hyperproliferative skin disorders. See the accompanying commentary. To learn more about the techniques used in this paper, visit the Research Techniques Made Simple article.
Zhang et al. find that Candida albicans, which grows as both a commensal and a pathogen at barrier sites in humans, releases variable amounts of extracellular ATP and that strains that secrete lower levels are associated with increased infection. These findings suggest that eATP release by C. albicans may induce inflammasome activation and promote host defense against the organism. See the accompanying commentary.

Most Downloaded JID Articles Published Since 2014

2020 Cited articles

Current Issue

September 2021
Volume 141, Issue 9

Meet the Editors of the JID Family of Journals


Dr. Janet A. Fairley, President of the Society for Investigative Dermatology leads an engaging conversation with Dr. Mark C. Udey, Editor-in-Chief of the Journal of Investigative Dermatology as well as Dr. Russell P. Hall III, Editor-in-Chief of our newest journal, JID Innovations.

May 2021 Supplement Issue

COVID-19 and the JID

Call for Submissions on Autoimmunity

JID invites submission of original articles for a Special Issue on Autoimmunity. Areas of interest include autoimmune disease, T-cell and B-cell biology in the context of autoimmune disease, antigen presentation, novel in vitro, or in vivo animal models, tolerance, innate immune response in autoimmune responses, including autoinflammatory response/diseases, mechanisms of sex-bias, and therapeutics in relation to autoimmunity. Submission deadline: April 1, 2021. Contact the Editor at [email protected] for submission details. Use the subject heading “Autoimmunity Issue.” For additional details, please see the full announcement.

Journal Metrics

8.551
2020
Impact Factor

28 days
average to first
decision

List of Issues

Supports Open Access


This journal has an open archive

Learn more about open access options.

 

19 February 2021:  Table of Contents March 2021 issue of the JID

Read the article
View more videos

Social Media

Advertisement